These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 26563374)

  • 1. Differential expression of ligands for NKG2D and DNAM-1 receptors by epithelial ovarian cancer-derived exosomes and its influence on NK cell cytotoxicity.
    Labani-Motlagh A; Israelsson P; Ottander U; Lundin E; Nagaev I; Nagaeva O; Dehlin E; Baranov V; Mincheva-Nilsson L
    Tumour Biol; 2016 Apr; 37(4):5455-66. PubMed ID: 26563374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.
    El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP
    Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer exosomes and NKG2D receptor-ligand interactions: impairing NKG2D-mediated cytotoxicity and anti-tumour immune surveillance.
    Mincheva-Nilsson L; Baranov V
    Semin Cancer Biol; 2014 Oct; 28():24-30. PubMed ID: 24602822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.
    Sayitoglu EC; Georgoudaki AM; Chrobok M; Ozkazanc D; Josey BJ; Arif M; Kusser K; Hartman M; Chinn TM; Potens R; Pamukcu C; Krueger R; Zhang C; Mardinoglu A; Alici E; Temple HT; Sutlu T; Duru AD
    Front Immunol; 2020; 11():40. PubMed ID: 32082316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function.
    Hedlund M; Stenqvist AC; Nagaeva O; Kjellberg L; Wulff M; Baranov V; Mincheva-Nilsson L
    J Immunol; 2009 Jul; 183(1):340-51. PubMed ID: 19542445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: mechanism of immune evasion.
    Lundholm M; Schröder M; Nagaeva O; Baranov V; Widmark A; Mincheva-Nilsson L; Wikström P
    PLoS One; 2014; 9(9):e108925. PubMed ID: 25268476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct Roles for Human Cytomegalovirus Immediate Early Proteins IE1 and IE2 in the Transcriptional Regulation of MICA and PVR/CD155 Expression.
    Pignoloni B; Fionda C; Dell'Oste V; Luganini A; Cippitelli M; Zingoni A; Landolfo S; Gribaudo G; Santoni A; Cerboni C
    J Immunol; 2016 Nov; 197(10):4066-4078. PubMed ID: 27733551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NKG2D-mediated cytotoxicity improves after primary surgery for high-grade serous ovarian cancer.
    Israelsson P; Björk E; Nagaev I; Nagaeva O; Lundin E; Mincheva-Nilsson L; Ottander U
    Am J Reprod Immunol; 2023 Jan; 89(1):e13647. PubMed ID: 36335434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells.
    Carlsten M; Björkström NK; Norell H; Bryceson Y; van Hall T; Baumann BC; Hanson M; Schedvins K; Kiessling R; Ljunggren HG; Malmberg KJ
    Cancer Res; 2007 Feb; 67(3):1317-25. PubMed ID: 17283169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune profile of primary and recurrent epithelial ovarian cancer cases indicates immune suppression, a major cause of progression and relapse of ovarian cancer.
    Kumar P; Ranmale S; Mehta S; Tongaonkar H; Patel V; Singh AK; Mania-Pramanik J
    J Ovarian Res; 2023 Jun; 16(1):114. PubMed ID: 37322531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications.
    Chitadze G; Bhat J; Lettau M; Janssen O; Kabelitz D
    Scand J Immunol; 2013 Aug; 78(2):120-9. PubMed ID: 23679194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human tumor-derived exosomes down-modulate NKG2D expression.
    Clayton A; Mitchell JP; Court J; Linnane S; Mason MD; Tabi Z
    J Immunol; 2008 Jun; 180(11):7249-58. PubMed ID: 18490724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications.
    Jimenez-Perez MI; Jave-Suarez LF; Ortiz-Lazareno PC; Bravo-Cuellar A; Gonzalez-Ramella O; Aguilar-Lemarroy A; Hernandez-Flores G; Pereira-Suarez AL; Daneri-Navarro A; del Toro-Arreola S
    BMC Immunol; 2012 Feb; 13():7. PubMed ID: 22316211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients.
    Mirjačić Martinović KM; Babović NLj; Džodić RR; Jurišić VB; Tanić NT; Konjević GM
    Melanoma Res; 2014 Aug; 24(4):295-304. PubMed ID: 24769842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutlin-3a Enhances Natural Killer Cell-Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors.
    Veneziani I; Infante P; Ferretti E; Melaiu O; Battistelli C; Lucarini V; Compagnone M; Nicoletti C; Castellano A; Petrini S; Ognibene M; Pezzolo A; Di Marcotullio L; Bei R; Moretta L; Pistoia V; Fruci D; Barnaba V; Locatelli F; Cifaldi L
    Cancer Immunol Res; 2021 Feb; 9(2):170-183. PubMed ID: 33303573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermal- and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia/lymphoma T and B cells.
    Hedlund M; Nagaeva O; Kargl D; Baranov V; Mincheva-Nilsson L
    PLoS One; 2011 Feb; 6(2):e16899. PubMed ID: 21364924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human breast tumor cells induce self-tolerance mechanisms to avoid NKG2D-mediated and DNAM-mediated NK cell recognition.
    Mamessier E; Sylvain A; Bertucci F; Castellano R; Finetti P; Houvenaeghel G; Charaffe-Jaufret E; Birnbaum D; Moretta A; Olive D
    Cancer Res; 2011 Nov; 71(21):6621-32. PubMed ID: 21937679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.
    Wrobel P; Shojaei H; Schittek B; Gieseler F; Wollenberg B; Kalthoff H; Kabelitz D; Wesch D
    Scand J Immunol; 2007; 66(2-3):320-8. PubMed ID: 17635809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.
    Song H; Kim J; Cosman D; Choi I
    Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of MMP activity can restore NKG2D ligand expression in gastric cancer, leading to improved NK cell susceptibility.
    Shiraishi K; Mimura K; Kua LF; Koh V; Siang LK; Nakajima S; Fujii H; Shabbir A; Yong WP; So J; Takenoshita S; Kono K
    J Gastroenterol; 2016 Dec; 51(12):1101-1111. PubMed ID: 27002316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.